Literature DB >> 6811289

Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.

T A De Kretser, M J Crumpton, J G Bodmer, W F Bodmer.   

Abstract

The SDR1 monoclonal antibody reacts only with cells which express the HLA-DR1, 2,w6 or w8 allogeneic specificities. Two-dimensional nonequilibrium pH gradient/sodium dodecyl sulfate polyacrylamide gel electrophoretic analyses of SDR1 immunoprecipitates from [35S]methionine biosynthetically labeled cells revealed the typical pattern of Ia antigens, namely two polypeptides of about 34kDa and 29kDa (designated epsilon and beta-3) as well as the "basic invariant spot" of about 31 kDa. The epsilon and beta-3 polypeptides were only weakly represented in similar analyses of immunoprecipitates performed using a monomorphic HLA-DR monoclonal antibody, TDR31.1. The epsilon and beta-3 polypeptides of B lymphoblastoid cell lines homozygous for HLA-DR2 and w6 were structurally polymorphic as judged by two-dimensional gel analyses. This polymorphism was independent of the HLA-DR specificity. It is concluded that the SDR1 antibody recognizes a polymorphic set of Ia antigens that are coded by a locus other than HLA-DR. These antigens probably also express the MT1 (DC1, LB12) alloantigenic specificity and are most likely the human equivalent of the murine I-A subregion antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811289     DOI: 10.1002/eji.1830120713

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells.

Authors:  D M Altmann; J M Heyes; H Ikeda; A M Sadler; D Wilkinson; J A Madrigal; J G Bodmer; J Trowsdale
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Comparison of human ZFY and ZFX transcripts.

Authors:  M S Palmer; P Berta; A H Sinclair; B Pym; P N Goodfellow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Interpretation of the specificities of monoclonal antibodies recognising human MHC class II antigens.

Authors:  K Guy; C M Steel
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

4.  Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation.

Authors:  D M O'Sullivan; D Noonan; V Quaranta
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

5.  Detection of a novel HLA-DQ specificity. II. Cellular analysis by cytotoxic T-cell clones.

Authors:  H Kojima; Y Fukasawa; N Ishikawa; Y Tajima; A Wakisaka; M Aizawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion.

Authors:  R C Giles; R DeMars; C C Chang; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Detection of a novel HLA-DQ specificity: serological and immunochemical analyses by a monoclonal antibody.

Authors:  N Ishikawa; H Kojima; T Nakayama; H Kunikane; S Hawkin; Y Fukasawa; H Ikeda; K Ogasawara; M Kasahara; Y Tajima
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.

Authors:  R E Bontrop; E J Baas; N Otting; G M Schreuder; M J Giphart
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

9.  The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.

Authors:  T Yabe; M Suzuki; M Satake; T Juji; H Hamaguchi
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types.

Authors:  R S Spielman; J Lee; W F Bodmer; J G Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.